Search research articles
Contact Us
Filters
Showing results (11-20 of 20) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 20 results.
Cancer Immunology Research
|
September 6, 2014
A transient increase in eosinophils is associated with prolonged survival in men with metastatic castration-resistant prostate cancer who receive sipuleucel-T
Douglas G McNeel, Thomas A Gardner, Celestia S Higano, et al.
Journal of the National Cancer Institute
|
March 8, 2020
Putting the Pieces Together: Completing the Mechanism of Action Jigsaw for Sipuleucel-T
Ravi A Madan, Emmanuel S Antonarakis, Charles G Drake, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 1, 2015
A Randomized Phase II Trial of Sipuleucel-T with Concurrent versus Sequential Abiraterone Acetate plus Prednisone in Metastatic Castration-Resistant Prostate Cancer
Eric J Small, Raymond S Lance, Thomas A Gardner, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 14, 2023
Combination Treatment with Sipuleucel-T and Abiraterone Acetate or Enzalutamide for Metastatic Castration-Resistant Prostate Cancer: STAMP and STRIDE Trials
Emmanuel S Antonarakis, Sumit K Subudhi, Christopher M Pieczonka, et al.
Cancer Immunology, Immunotherapy : CII
|
August 7, 2012
Sipuleucel-T immune parameters correlate with survival: an analysis of the randomized phase 3 clinical trials in men with castration-resistant prostate cancer
Nadeem A Sheikh, Daniel Petrylak, Philip W Kantoff, et al.
Journal of the National Cancer Institute
|
September 27, 2014
Activated lymphocyte recruitment into the tumor microenvironment following preoperative sipuleucel-T for localized prostate cancer
Lawrence Fong, Peter Carroll, Vivian Weinberg, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 3, 2018
Antigen-Specific CD8 Lytic Phenotype Induced by Sipuleucel-T in Hormone-Sensitive or Castration-Resistant Prostate Cancer and Association with Overall Survival
Emmanuel S Antonarakis, Eric J Small, Daniel P Petrylak, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 13, 2016
Sequencing of Sipuleucel-T and Androgen Deprivation Therapy in Men with Hormone-Sensitive Biochemically Recurrent Prostate Cancer: A Phase II Randomized Trial
Emmanuel S Antonarakis, Adam S Kibel, Evan Y Yu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 5, 2015
Humoral Immune Response against Nontargeted Tumor Antigens after Treatment with Sipuleucel-T and Its Association with Improved Clinical Outcome
Debraj GuhaThakurta, Nadeem A Sheikh, Li-Qun Fan, et al.
Prostate Cancer and Prostatic Diseases
|
March 1, 2020
Survival of African-American and Caucasian men after sipuleucel-T immunotherapy: outcomes from the PROCEED registry
Oliver Sartor, Andrew J Armstrong, Chiledum Ahaghotu, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 20) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 20 results.
Cancer Immunology Research
|
September 6, 2014
A transient increase in eosinophils is associated with prolonged survival in men with metastatic castration-resistant prostate cancer who receive sipuleucel-T
Douglas G McNeel, Thomas A Gardner, Celestia S Higano, et al.
Journal of the National Cancer Institute
|
March 8, 2020
Putting the Pieces Together: Completing the Mechanism of Action Jigsaw for Sipuleucel-T
Ravi A Madan, Emmanuel S Antonarakis, Charles G Drake, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 1, 2015
A Randomized Phase II Trial of Sipuleucel-T with Concurrent versus Sequential Abiraterone Acetate plus Prednisone in Metastatic Castration-Resistant Prostate Cancer
Eric J Small, Raymond S Lance, Thomas A Gardner, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 14, 2023
Combination Treatment with Sipuleucel-T and Abiraterone Acetate or Enzalutamide for Metastatic Castration-Resistant Prostate Cancer: STAMP and STRIDE Trials
Emmanuel S Antonarakis, Sumit K Subudhi, Christopher M Pieczonka, et al.
Cancer Immunology, Immunotherapy : CII
|
August 7, 2012
Sipuleucel-T immune parameters correlate with survival: an analysis of the randomized phase 3 clinical trials in men with castration-resistant prostate cancer
Nadeem A Sheikh, Daniel Petrylak, Philip W Kantoff, et al.
Journal of the National Cancer Institute
|
September 27, 2014
Activated lymphocyte recruitment into the tumor microenvironment following preoperative sipuleucel-T for localized prostate cancer
Lawrence Fong, Peter Carroll, Vivian Weinberg, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 3, 2018
Antigen-Specific CD8 Lytic Phenotype Induced by Sipuleucel-T in Hormone-Sensitive or Castration-Resistant Prostate Cancer and Association with Overall Survival
Emmanuel S Antonarakis, Eric J Small, Daniel P Petrylak, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 13, 2016
Sequencing of Sipuleucel-T and Androgen Deprivation Therapy in Men with Hormone-Sensitive Biochemically Recurrent Prostate Cancer: A Phase II Randomized Trial
Emmanuel S Antonarakis, Adam S Kibel, Evan Y Yu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 5, 2015
Humoral Immune Response against Nontargeted Tumor Antigens after Treatment with Sipuleucel-T and Its Association with Improved Clinical Outcome
Debraj GuhaThakurta, Nadeem A Sheikh, Li-Qun Fan, et al.
Prostate Cancer and Prostatic Diseases
|
March 1, 2020
Survival of African-American and Caucasian men after sipuleucel-T immunotherapy: outcomes from the PROCEED registry
Oliver Sartor, Andrew J Armstrong, Chiledum Ahaghotu, et al.
Page
of 2